Patient outcomes following thyroid surgery for thyrotoxicosis

• Published in: Journal of laryngology and otology 2023-03, Vol.137 (3), p.308-311
• Main Authors: Selwyn, D, How-Hong, E, Tan, H, England, R J
• Format: Article
• Language: English
• Subjects: Graves disease; Graves Disease - surgery; Histology; Hormone replacement therapy; Humans; Hyperplasia; Hyperthyroidism; Hypocalcemia; Hypothyroidism; Main Article; Medical referrals; Neurological disorders; Observational studies; Paralysis; Patients; Remission (Medicine); Retrospective Studies; Surgery; Thyroid cancer; Thyroidectomy; Thyrotoxicosis; Thyrotoxicosis - complications; Thyrotoxicosis - surgery; Thyroxine; Tumors
• ISSN: 0022-2151; 1748-5460
• DOI: 10.1017/S0022215122000664

Total thyroidectomy can be used as a definitive treatment modality for thyrotoxicosis. This study assessed the outcomes of patients treated with surgery at a single secondary care site. A retrospective cohort study was conducted analysing consecutive patients who underwent thyroid surgery for thyrotoxicosis between 24 November 2000 and 26 April 2019 ( = 595). Total thyroidectomy was performed in 95.4 per cent of patients. Two-thirds of patients had Graves' disease histology. Of patients, 22.8 per cent became transiently hypothyroid whilst on levothyroxine (thyroid hormone replacement therapy). Transient and persistent hypocalcaemia was present in 23.3 per cent and 2.8 per cent of patients respectively. Recurrent laryngeal nerve palsy was transient and persistent in 3.6 per cent and 0.3 per cent respectively. Of patients, 2.5 per cent developed post-operative haematomas that required surgical evacuation in the operating theatre. The overall complication rate for thyroid surgery is higher in thyrotoxic than in euthyroid patients. Compared to other treatment modalities, total thyroidectomy appears to be the most effective, definitive means of managing Graves' disease.